Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Averett

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Hepatology|April 6, 1999
Ribavirin polarizes human T cell responses towards a Type 1 cytokine profileR C Tam, B Pai, J Bard, et al.
Journal of Medicinal Chemistry|April 29, 1994
An enantiospecific synthesis of the human cytomegalovirus antiviral agent [(R)-3-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-4- hydroxybutyl]phosphonic acidS D Chamberlain, K K Biron, R E Dornsife, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virusD R Averett, G W Koszalka, J A Fyfe, et al.
Cancer Research|August 1, 1995
2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignanciesC U Lambe, D R Averett, M T Paff, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1991
Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virusP de Miranda, T C Burnette, K K Biron, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virusG W Koszalka, D R Averett, J A Fyfe, et al.
Journal of Virology|December 1, 1994
Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducksI Fourel, J M Cullen, J Saputelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1985
Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibitionT Spector, D R Averett, D J Nelson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1989
2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovirT Spector, J A Harrington, R W Morrison, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1991
Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cellsR E Dornsife, M H St Clair, A T Huang, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Hepatology|April 6, 1999
Ribavirin polarizes human T cell responses towards a Type 1 cytokine profileR C Tam, B Pai, J Bard, et al.
Journal of Medicinal Chemistry|April 29, 1994
An enantiospecific synthesis of the human cytomegalovirus antiviral agent [(R)-3-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-4- hydroxybutyl]phosphonic acidS D Chamberlain, K K Biron, R E Dornsife, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virusD R Averett, G W Koszalka, J A Fyfe, et al.
Cancer Research|August 1, 1995
2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignanciesC U Lambe, D R Averett, M T Paff, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1991
Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virusP de Miranda, T C Burnette, K K Biron, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virusG W Koszalka, D R Averett, J A Fyfe, et al.
Journal of Virology|December 1, 1994
Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducksI Fourel, J M Cullen, J Saputelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1985
Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibitionT Spector, D R Averett, D J Nelson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1989
2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovirT Spector, J A Harrington, R W Morrison, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1991
Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cellsR E Dornsife, M H St Clair, A T Huang, et al.
Pageof 4